Immunological indicators of animal organisms under the influence of allogeneic adipose tissue derived mesenchymal stem cells
Abstract
Abstract. The studies were conducted on 2-3-months-old males of mice weighing 20-24 g. Оur work was to study the functional state of the organs of the immune system of C57Bl/6 mice after introduction of allogeneic MSCs of adipose tissue origin. Obtaining and cultivating of MSCs were carried out in a sterile laminar box with compliance of conditions of asepsis and antiseptics. C57Bl/6 mice adipose tissue cultured in a CO2 incubator at 37 оC and 5% CO2 inDMEM with 10-15% of fetal bovine serum, 1% of antibiotic-antimycotic solution (Sigma-Aldrich, USA). The following groups of animals were formed: 1 group – intact (control group); 2 group - animals, to whom 0.5 ml of 0.9% NaCl solution (placebo) were injected into the caudal vein; 3 group – animals, to whom were injected 104 of allogeneic MSCs from adipose tissue in 0.5 ml of phosphate buffer solution into the caudal vein. The weight index, content of lymphoid cells of thymus and spleen in C57Bl/6 mice investigated after the introduction of MSCs on 7, 18 and 25 days. To assess the content of lymphocytes in lymphoid organs, the latter were weighed. Whole thymus and 50 mg of spleen were triturated and filtered through the kapron tissue. After that, the tissue homogenate was applied to the gradient of ficoll-urografin (density 1.077) in a ratio of 3:2. The test tubes were centrifuged at a rate of 1500 rpm for 30-40 minutes. After centrifugation the layer of lymphocytes which was above the gradient was collected by a Pasteur pipette and washed twice with an arbitrary amount of Hanks' solution by centrifugation at a rate of 1500 for 10 minutes. 1 ml of Hanks's solution was added to lymphocytes after washing. Lymphocytes were counted in the Goryaev chamber. Calculation of the cells of lymphoid organs was performed on 1 mg of tissue.
The administration of allogenic adipose derived mesenchymal stem cells affects on the central and peripheral organs of the immune system. Administration of allogenic adipose derived mesenchymal stem cells cause a significant increase in the content of lymphoid cells in the thymus at 7, 18 and 25 days by 71, 57 and 53 % respectively (*- p<0,05) compared to the control. Quantity lymphoid cells in the spleen significant increase at the 7 and 18 days of the immune response by 33 and 19 %, respectively (p<0.01, p <0.05) compared to the control under administration of allogenic adipose derived mesenchymal stem cells. On the 25th day, lymphoid cell and spleen index values return to normal. Weight index of the thymus and spleen directly correlates with the content of lymphoid cells in its.
Key words: thymus, spleen, lymphoid cells, mice, weight index, allogenic mesenchymal stem cells, adipose tissue
References
Aggarwal S., Pittenger M. G. Human mesenchymal stem cellsmodulate allogeneic immune cell responses // Blood. - 2005. - V.105. - P. 1815-1822.
https://doi.org/10.1182/blood-2004-04-1559
Arnhold S. Adipose tissue derived mesenchymal stem cells for musculoskeletal repair in veterinary medicine/ S. Arnhold , S. Wenisch // Am. J. Stem Cells. 2015; 4(1): 1-12.
Bartholomew A., Sturgeon C., Siatskas M. et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo // Exp. Hematol. - 2002. - Vol. 30. - P. 42-48.
https://doi.org/10.1016/S0301-472X(01)00769-X
Batten P., Sarathchandra P., Antoniw J.W., Tay S.S., Lowdell M.W., Taylor P.M., Yacoub M.H. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng., 2006, vol. 12, pp. 2263-2273.
https://doi.org/10.1089/ten.2006.12.2263
Di Nicola M., Carlo-Stella C., Magni M. et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli // Blood. - 2002. - Vol. 99. - P. 3838-3843.
https://doi.org/10.1182/blood.V99.10.3838
Djouad F., Fritz V., Apparailly F. et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis // Arthr. and Rheum. - 2005. - Vol. 52. - P. 1595-1603.
https://doi.org/10.1002/art.21012
Haghighat A. Adipose derived stem cells for treatment of mandibular bone defects: An autologous study in dogs/ A. Haghighat, A.Akhavan, B.Hashemi-Beni, P.Deihimi, A.Yadegari // Dent. Res. J. - 2011. - №8(Suppl 1):S5. - Р.1-7.
Huang Y., Johnston P., Zakari A. et al. Kidney-derived stromal cells modulate dendritic and T cell responses // J. Am. Soc. Nephrol. - 2009. - Vol. 20. - P. 831-841.
https://doi.org/10.1681/ASN.2008030310
Kathrine K. J. Mesenchymal stem cell therapy for laryngotracheal stenosis: A systematic review of preclinical studies / K. J. Kathrine., G.Christian, D. H. Jensen, A. Fischer-Nielsen, T. Hjuler, C. von Buchwald // PLOS ONE 21 Sep 2017, https://doi.org/10.1371/journal.pone.0185283
https://doi.org/10.1371/journal.pone.0185283
Kladnytska L. V. Influence allogeneic mesenchymal stem cells on the tumour growth parameters and metastatic potential in the transplantable
carcinoma lung Lewis / Kladnytska L. V., Nikulina V.V., Garmanchuk L. V., Mazurkevych A. Y., Kovpak V. V., Nikolaienko T. V., Shelest D. V., Dzhus O. I., Skachkova O.V., Stupak Y. A., Dasyukevich O. I./Journal of Animal and Veterinary Sciences. -2014.- Vol.1 , No. 1. - Pages: 1-5 .
Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J. Immunol., 2003, vol. 57, pp. 11-20.
https://doi.org/10.1046/j.1365-3083.2003.01176.x
Lu X., Liu T., Gu L., Huang C., Zhu H., Meng W., Xi Y., Li S., Liu Y. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets. Transpl. Immunol., 2009, vol. 22, pp. 55-61.
https://doi.org/10.1016/j.trim.2009.08.002
Marx C. Acupoint injection of autologous stromal vascular fraction and allogeneic adipose-derived stem cells to treat hip dysplasia in dogs. C. Marx, M.D. Silveira, I.Selbach, A.S. da Silva, L.M. Braga, M.Camassola, N.B. Nardi / Stem Cells. - 2014. - 2014:391274
https://doi.org/10.1155/2014/391274
Reich C. Isolation, culture and chondrogenic differentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells a comparative study/ C.Reich, O.Raabe, S.Wenisch, P.Bridger, M.Kramer, S.Arnhold // Vet. Res. Commun. - 2012; - № 2. - Р.139-148.
https://doi.org/10.1007/s11259-012-9523-0
Grischenko V.A., Tomchuk V.A. ImunomodulyuyuchI vlastivostI lIposom na osnovI fosfolIpIdIv moloka pri ImunodefItsItnomu stanI organIzmu tvarin. Naukoviy vIsnik NUBIP UkraYini. - 2013. - Vip.188, ch.4. - s.107-115
Kladnitska L.V. Ekspresiya tsitoplazmatichnih bilkiv stovburovimi klitinami z zhirovoyi tkanini sobaki na rіznih pasazhah kultivuvannya in vitro/L. V. Kladnitska, A. Y. Mazurkevich, N. O. Bezdenezhnih, V. F. Chehun, S. V. Velichko, M. O. Malyuk, T. V. Kozitska, V. V. Kovpak, V. B. Danilov, Yu. O. Harkevich.// Naukovo-tehnichniy byuleten naukovo-doslidnogo kontrolnogo Institutu veterinarnih preparatIv i kormovih dobavok institutu biologiyi tvarin . Vipusk 18, # 1, Lviv - 2017, s. 48-55
Nikolskaya V. V. Vliyanie vnutrivennogo vvedeniya multipotentnyih stromalnyih kletok timusa na proliferativnuyu fazu immunnogo otveta / V. V. Nikolskaya, V. O. Savinova, Ya.-M. O. Semenova, L. I. Taranuha, I. S. Nikolskiy// Zhurnal NAMN UkraYini. - 2012, - t. 18, dodatok. - s. 105-106.
Patent Ukrayini na korisnu model #109148. Sposіb otrimannya mezenhіmalnih stovburovih klіtin іz zhirovoуi tkanуnу sobaki/ L.V.Kladnitska, A.Y. Mazurkevich, S.V.Velichko.; zayavnik i vlasnik Natsionalniy unIversitet bioresursiv i prirodokoristuvannya Ukraуini. # u 201602329; zayavl. 11.03.2016; opubl. 10.08.2016, byul.#15.
Downloads
Issue
Section
License
Relationship between right holders and users shall be governed by the terms of the license Creative Commons Attribution – non-commercial – Distribution On Same Conditions 4.0 international (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).